Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Umbilical-cord Mesenchymal Stem Cells in Chinese Adults With Type 2 Diabetes: a Single Center, Double-blind, Randomized, Placebo-controlled Trial
Conditions
Interventions
Umbilical cord mesenchymal stem cells
Controlled suspension liquid
Locations
1
China
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Start Date
January 1, 2013
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
February 3, 2021
NCT06815081
NCT06278207
NCT07051005
NCT07296484
NCT06671587
NCT06688461
Lead Sponsor
Chinese PLA General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions